Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Cyclin-dependent kinases (CDKs) play a central role in cell cycle control, apoptosis, transcription, and neuronal functions. They are important targets for the design of drugs with antimitotic or antineurodegenerative effects. CDK4 and CDK6 form a subfamily among the CDKs in mammalian cells, as defined by sequence similarities. Compared to CDK2 and CDK5, structural information on CDK4 and CDK6 is sparse. We describe here the crystal structure of human CDK6 in complex with a viral cyclin and a flavonol inhibitor, fisetin. Fisetin binds to the active form of CDK6, forming hydrogen bonds with the side chains of residues in the binding pocket that undergo large conformational changes during CDK activation by cyclin binding. The 4-keto group and the 3-hydroxyl group of fisetin are hydrogen bonded with the backbone in the hinge region between the N-terminal and C-terminal kinase domain, as has been observed for many CDK inhibitors. However, CDK2 and HCK kinase in complex with other flavone inhibitors such as quercetin and flavopiridol showed a different binding mode with the inhibitor rotated by about 180 degrees. The structural information of the CDK6-fisetin complex is correlated with the binding affinities of different flavone inhibitors for CDK6. This complex structure is the first description of an inhibitor complex with a kinase from the CDK4/6 subfamily and can provide a basis for selecting and designing inhibitor compounds with higher affinities and specificities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 27
- Sherr C. J, 1993, Cell, 73, 1065, 10.1016/0092-8674(93)90636-5 · DOI · Paper page
- Morgan D, 1995, Nature, 374, 134, 10.1038/374131a0 · DOI · Paper page
- Pavletich N. P, 1999, J. Mol. Biol., 287, 828, 10.1006/jmbi.1999.2640 · DOI · Paper page
- Levine A. J., 1997, Cell, 88, 331, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
- Hunter T., 1994, Cell, 79, 583, 10.1016/0092-8674(94)90543-6 · DOI · Paper page
- Sausville E. A, 2002, Trends Mol. Med., 8, S37, 10.1016/S1471-4914(02)02308-0 · DOI · Paper page
- Noble M. E., 2004, Science, 303, 1805, 10.1126/science.1095920 · DOI · Paper page
- Dai Y., 2004, Curr. Oncol. Rep., 6, 130
- Fischer P. M., 2003, Prog. Cell Cycle Res., 5, 248
- Knockaert M., 2002, Trends Pharmacol. Sci., 23, 425, 10.1016/S0165-6147(02)02071-0 · DOI · Paper page
- Meijer L., 2003, Acc. Chem. Res., 36, 425, 10.1021/ar0201198 · doi:10.1021/ar0201198
- Schulze-Gahmen U., 2002, Nat. Struct. Biol., 9, 181
- Taylor S. S., 1994, Structure, 2, 355, 10.1016/S0969-2126(00)00036-8 · DOI · Paper page
- Jeffrey D. P., 1995, Nature, 376, 320, 10.1038/376313a0 · DOI · Paper page
- De Azevedo W. F., 1997, Eur. J. Biochem., 243, 526, 10.1111/j.1432-1033.1997.0518a.x · DOI · Paper page
- Sicheri F., 1997, Nature, 385, 609, 10.1038/385602a0 · DOI · Paper page
- Pettit G. R. H., 1996, J. Ethnopharmacol., 53, 63
- Schulze-Gahmen U., 2001, Sect. D: Biol. Crystallogr.
- Otwinowski Z., 1997, Methods Enzymol., 276, 326, 10.1016/S0076-6879(97)76067-1 · DOI · Paper page
- Collaborative Computational Project, N., 1994, Sect. D: Biol. Crystallogr.
- Brunger A. T., 1998, Sect. D: Biol. Crystallogr.
- Jones T. A., 1991, Sect. A: Found. Crystallogr.
- Sheriff S., 1987, J. Mol. Biol., 197, 296, 10.1016/0022-2836(87)90124-0 · DOI · Paper page
- Connolly M. L, 1983, J. Appl. Crystallogr., 16, 558, 10.1107/S0021889883010985 · DOI · Paper page
- Rossman M. G., 1975, J. Biol. Chem., 250, 7532
- Schulze-Gahmen U., 1996, J. Med. Chem., 39, 4546, 10.1021/jm960402a · DOI · Paper page
- Davies T. G., 2002, Nat. Struct. Biol., 9, 749, 10.1038/nsb842 · DOI · Paper page
Cited by
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Molecular targets of phytochemicals for cancer prevention
Lee, K. W., Bode, A. M., & Dong, Z. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3017 · Cited by 426
Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
Kashyap, D., Garg, V. K., Tuli, H. S., Yerer, M. B., Sak, K., Sharma, A. K., Kumar, M., Aggarwal, V., & Sandhu, S. S. (2019) · Biomolecules · doi:10.3390/biom9050174 · Cited by 285
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160
Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite
Touil, Y. S., Auzeil, N., Boulinguez, F., Saighi, H., Regazzetti, A., Scherman, D., & Chabot, G. G. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.097 · Cited by 111
“[20] Lu H, Chang DJ, Baratte B, Meijer L, Schulze-Gahmen U.”
Background
Metadata
- Authors
- Lu, H., Chang, D. J., Baratte, B., Meijer, L., & Schulze-Gahmen, U.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-01-20
- Volume
- 48
- Issue
- 3
- Pages
- 737-743
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2116096636
- Cited by
- 147
- References
- 4
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin. https://app.cochat.ai/papers/10.1021/jm049353p
- The paper
- Lu, H., Chang, D. J., Baratte, B., Meijer, L., & Schulze-Gahmen, U. (2005). Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin. Journal of Medicinal Chemistry. https://doi.org/10.1021/jm049353p
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.